Pinkal Desai is an Oncology physician affiliated with NewYork–Presbyterian Hospital. OpenAlex indexes 204 publications with 4,018 citations (h-index 29); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
520 E 70th St
Starr 341
New York, NY 100219800
Telephone
646-962-2700Registry record last updated 4 Oct 2013.
Clinical trials
- Luspatercept for Clonal Cytopenias of Uncertain Significance
Sponsor: Weill Medical College of Cornell University
- A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms
Sponsor: Weill Medical College of Cornell University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20254 payments$11,943openpaymentsdata.cms.gov ↗
- Astellas Pharma US IncProgram year20252 payments
- ABBVIE INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2021–2025 per NIH RePORTER. The latest:
- Pre-malignant mutation landscape and risk factors for progression to hematologic cancers
Weill Medical Coll of Cornell Univ
FY2025$625,214R01CA248747 - Pre-malignant mutation landscape and risk factors for progression to hematologic cancers
Weill Medical Coll of Cornell Univ
FY2024$594,978R01CA248747 - Pre-malignant mutation landscape and risk factors for progression to hematologic cancers
Weill Medical Coll of Cornell Univ
FY2023$650,905R01CA248747
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women
Journal of the American College of Cardiology
2025 - Clonal Hematopoiesis and Incident Heart Failure With Preserved Ejection Fraction
JAMA Network Open
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Lawrence Honig, MD, PhD
NewYork–Presbyterian Hospital
Nasser Altorki, MD
NewYork–Presbyterian Hospital
Michael Niederman, MD
NewYork–Presbyterian Hospital
Shunichi Homma, MD
NewYork–Presbyterian Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”